Elekta AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EKTAY research report →
About the company
Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse patient radiotherapy requirements, and the Elekta Synergy digital accelerator for advanced image-guided radiation therapy. Specific solutions like Versa HD are available for managing brain metastases.
- CEO
- Jakob Just-Bomholt
- IPO
- 2009
- Employees
- 4,541
- HQ
- Stockholm, SE
Price Chart
- Market Cap
- $2.02B
- P/E
- -38.63
- P/S
- 1.15
- P/B
- 2.83
- EV/EBITDA
- 13.36
- Div Yield
- 4.59%
- Gross Margin
- 37.39%
- Op Margin
- 5.29%
- Net Margin
- -3.10%
- ROE
- -6.37%
- ROIC
- 5.87%
- Revenue
- $16.39B · -9.04%
- Net Income
- $-509,739,618 · -315.08%
- EPS
- $-1.29 · -308.06%
- Op Income
- $425.44M
- FCF YoY
- 117.59%
- 52W High
- $6.93
- 52W Low
- $4.35
- 50D MA
- $5.71
- 200D MA
- $5.73
- Beta
- 0.95
- Avg Volume
- 1.89K
Get TickerSpark's AI analysis on EKTAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EKTAY coverage
Recent articles, reports, and earnings notes.
No research on EKTAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EKTAY report →Similar companies
Peers in the same neighborhood.